Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
2.
Pediatr Endocrinol Rev ; 7(1): 22-31, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19696713

RESUMO

The migration of the testes from the abdomen into the scrotum requires both an anatomical change in connecting structures and regulating signals to mediate this process. The gubernaculum is the principle structure in testicular descent. Its development appears to be controlled by insulin-like hormone 3 (INSL3) and androgen. This review article summarises the role of INSL3 and androgen in testicular descent. It also analyses the contribution of other hormones such as Mullerian inhibiting substance (MIS) and oestrogen to testicular descent. Furthermore, it reiterates findings that hormonal activation of the nervous system leads to neuropeptide secretion and further manipulation of this process.


Assuntos
Androgênios/metabolismo , Insulina/metabolismo , Proteínas/metabolismo , Testículo/embriologia , Testículo/metabolismo , Animais , Hormônio Antimülleriano/metabolismo , Estrogênios/metabolismo , Humanos , Masculino
3.
J Pediatr Surg ; 46(12): 2358-62, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22152882

RESUMO

BACKGROUND/PURPOSE: Inguinoscrotal testicular descent is controlled by androgens between embryonic days E16-19, but androgen receptor (AR) and estrogen receptor (ER) locations are unknown. We aimed to find AR, ERα, and ERß in the gubernaculum and inguinal fat pad (IFP) in normal rats and after flutamide treatment. METHODS: Sprague-Dawley timed-mated rats were injected with flutamide (75 mg/kg body weight/5% ethanol + oil) on E16-19 or vehicle alone. Male fetuses or pups (5-10/group) were collected at E16; E19; and postnatal (P) days 0, 2, 4, 8. Sections were prepared for hematoxylin and eosin or immunohistochemistry for AR, ERα, and ERß. Receptor labeling was quantitated as distinct nuclear labeling/100 µm(2) in gubernaculum and IFP. RESULTS: There was minimal gubernacular AR-labeling until E19, dramatically increasing postnatally. By contrast, at E16-E19 there was significant IFP AR immunoreactivity suppressed by flutamide (P < .05). No ERα expression was observed, but ERß was expressed in both gubernaculum and IFP, maximally at E16, but unchanged by flutamide. CONCLUSIONS: During the androgen sensitivity window (E16-19), the gubernaculum contains ERß but minimal ERα or AR, while the IFP, which is supplied by the genitofemoral nerve, contains abundant AR that are flutamide-sensitive. These results suggest that the IFP could be the site of androgenic action controlling gubernacular development.


Assuntos
Antagonistas de Androgênios/farmacologia , Receptor alfa de Estrogênio/efeitos dos fármacos , Receptor beta de Estrogênio/efeitos dos fármacos , Flutamida/farmacologia , Gordura Intra-Abdominal/efeitos dos fármacos , Ligamentos/efeitos dos fármacos , Receptores Androgênicos/efeitos dos fármacos , Testículo/embriologia , Animais , Núcleo Celular/química , Criptorquidismo/fisiopatologia , Receptor alfa de Estrogênio/biossíntese , Receptor alfa de Estrogênio/genética , Receptor beta de Estrogênio/biossíntese , Receptor beta de Estrogênio/genética , Feminino , Nervo Femoral/fisiologia , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Idade Gestacional , Gordura Intra-Abdominal/embriologia , Gordura Intra-Abdominal/crescimento & desenvolvimento , Gordura Intra-Abdominal/inervação , Gordura Intra-Abdominal/metabolismo , Ligamentos/embriologia , Ligamentos/crescimento & desenvolvimento , Ligamentos/metabolismo , Masculino , Glândulas Mamárias Animais/embriologia , Glândulas Mamárias Animais/crescimento & desenvolvimento , Glândulas Mamárias Animais/metabolismo , Gravidez , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Receptores Androgênicos/biossíntese , Receptores Androgênicos/genética , Escroto/embriologia , Escroto/crescimento & desenvolvimento , Testículo/crescimento & desenvolvimento , Testosterona/fisiologia
4.
J Pediatr Surg ; 45(10): 2074-86, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20920735

RESUMO

It has been hypothesized that poor semen quality, testis cancer, undescended testis, and hypospadias are symptoms of one underlying entity--the testicular dysgenesis syndrome--leading to increasing male fertility impairment. Though testicular cancer has increased in many Western countries during the past 40 years, hypospadias rates have not changed with certainty over the same period. Also, recent studies demonstrate that sperm output may have declined in certain areas of Europe but is probably not declining across the globe as indicated by American studies. However, at the same time, there is increasing recognition of male infertility related to obesity and smoking. There is no certain evidence that the rates of undescended testes have been increasing with time during the last 50 years. In more than 95% of the cases, hypospadias is not associated with cryptorchidism, suggesting major differences in pathogenesis. Placental abnormality may occasionally cause both cryptorchidism and hypospadias, as it is also the case in many other congenital malformations. The findings of early orchidopexy lowering the risk of both infertility and testicular cancer suggest that the abnormal location exposes the cryptorchid testis to infertility and malignant transformation, rather than there being a primary abnormality. Statistically, 5% of testicular cancers only are caused by cryptorchidism. These data point to the complexity of pathogenic and epidemiologic features of each component and the difficulties in ascribing them to a single unifying process, such as testicular dysgenesis syndrome, particularly when so little is known of the actual mechanisms of disease.


Assuntos
Criptorquidismo/etiologia , Disgenesia Gonadal/complicações , Hipospadia/etiologia , Criptorquidismo/epidemiologia , Criptorquidismo/genética , Seguimentos , Disgenesia Gonadal/epidemiologia , Disgenesia Gonadal/etiologia , Humanos , Hipospadia/epidemiologia , Hipospadia/genética , Lactente , Recém-Nascido , Masculino , Modelos Biológicos , Neoplasias Testiculares/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA